-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Analyzing Upexi (NASDAQ:UPXI) and Exactus (OTCMKTS:EXDI)
Analyzing Upexi (NASDAQ:UPXI) and Exactus (OTCMKTS:EXDI)
Upexi (NASDAQ:UPXI – Get Rating) and Exactus (OTCMKTS:EXDI – Get Rating) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, risk and profitability.
Profitability
This table compares Upexi and Exactus' net margins, return on equity and return on assets.
Get Upexi alerts:Net Margins | Return on Equity | Return on Assets | |
Upexi | -9.97% | -13.93% | -9.55% |
Exactus | N/A | -3,272.69% | -185.29% |
Analyst Ratings
This is a summary of current ratings and price targets for Upexi and Exactus, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Upexi | 0 | 0 | 1 | 0 | 3.00 |
Exactus | 0 | 0 | 0 | 0 | N/A |
Institutional and Insider Ownership
3.1% of Upexi shares are owned by institutional investors. Comparatively, 0.1% of Exactus shares are owned by institutional investors. 55.0% of Upexi shares are owned by insiders. Comparatively, 65.0% of Exactus shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Risk & Volatility
Upexi has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500. Comparatively, Exactus has a beta of 4.21, meaning that its stock price is 321% more volatile than the S&P 500.
Earnings & Valuation
This table compares Upexi and Exactus' gross revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Upexi | $44.58 million | 1.16 | -$2.10 million | N/A | N/A |
Exactus | $2.07 million | 28.07 | -$9.46 million | N/A | N/A |
Upexi has higher revenue and earnings than Exactus.
Summary
Upexi beats Exactus on 7 of the 11 factors compared between the two stocks.
About Upexi
(Get Rating)
Upexi, Inc. manufacture and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Clearwater, Florida.
About Exactus
(Get Rating)
Exactus, Inc., is a farmer and manufacturer of hemp-derived phytocannabinoid products. The company sells its CBD products through its Green Goddess brand and third-party resellers. Exactus is engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3 percent or less. THC is the psychoactive compound found in cannabis.
Receive News & Ratings for Upexi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Upexi and related companies with MarketBeat.com's FREE daily email newsletter.
Upexi (NASDAQ:UPXI – Get Rating) and Exactus (OTCMKTS:EXDI – Get Rating) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, risk and profitability.
纳斯达克:UPXI-GET Rating和Exactus(OTCMKTS:EXDI-GET Rating)都是小盘股企业服务公司,但哪只股票更好?我们将根据两家公司的估值、收益、分析师建议、机构所有权、股息、风险和盈利能力等方面的实力进行比较。
Profitability
盈利能力
This table compares Upexi and Exactus' net margins, return on equity and return on assets.
下表比较了Upexi和Exactus的净利润率、股本回报率和资产回报率。
Net Margins | Return on Equity | Return on Assets | |
Upexi | -9.97% | -13.93% | -9.55% |
Exactus | N/A | -3,272.69% | -185.29% |
净利润率 | 股本回报率 | 资产回报率 | |
Upexi | -9.97% | -13.93% | -9.55% |
Exactus | 不适用 | -3,272.69% | -185.29% |
Analyst Ratings
分析师评级
This is a summary of current ratings and price targets for Upexi and Exactus, as reported by MarketBeat.
据MarketBeat报道,这是Upexi和Exactus目前的评级和目标价摘要。
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Upexi | 0 | 0 | 1 | 0 | 3.00 |
Exactus | 0 | 0 | 0 | 0 | N/A |
销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
Upexi | 0 | 0 | 1 | 0 | 3.00 |
Exactus | 0 | 0 | 0 | 0 | 不适用 |
Institutional and Insider Ownership
机构和内部人持股
3.1% of Upexi shares are owned by institutional investors. Comparatively, 0.1% of Exactus shares are owned by institutional investors. 55.0% of Upexi shares are owned by insiders. Comparatively, 65.0% of Exactus shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Upexi 3.1%的股份由机构投资者持有。相比之下,Exactus 0.1%的股份由机构投资者持有。55.0%的Upexi股份由内部人士持有。相比之下,Exactus 65.0%的股份由内部人士持有。强大的机构持股表明,大型基金管理公司、对冲基金和捐赠基金相信,一家公司有望实现长期增长。
Risk & Volatility
风险与波动性
Upexi has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500. Comparatively, Exactus has a beta of 4.21, meaning that its stock price is 321% more volatile than the S&P 500.
Upexi的贝塔系数为1.27,这意味着其股价的波动性比标准普尔500指数高27%。相比之下,Exactus的贝塔系数为4.21,这意味着其股价的波动性比标准普尔500指数高出321%。
Earnings & Valuation
收益与估值
This table compares Upexi and Exactus' gross revenue, earnings per share and valuation.
下表比较了Upexi和Exactus的毛收入、每股收益和估值。
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Upexi | $44.58 million | 1.16 | -$2.10 million | N/A | N/A |
Exactus | $2.07 million | 28.07 | -$9.46 million | N/A | N/A |
总收入 | 价格/销售额比 | 净收入 | 每股收益 | 市盈率 | |
Upexi | 4458万美元 | 1.16 | -210万元 | 不适用 | 不适用 |
Exactus | 207万美元 | 28.07 | -946万美元 | 不适用 | 不适用 |
Upexi has higher revenue and earnings than Exactus.
Upexi的收入和收益比Exactus更高。
Summary
摘要
Upexi beats Exactus on 7 of the 11 factors compared between the two stocks.
在比较两只股票的11个因素中,Upexi有7个胜过Exactus。
About Upexi
关于Upexi
(Get Rating)
(获取评级)
Upexi, Inc. manufacture and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Clearwater, Florida.
Upexi,Inc.在健康、保健、宠物、美容等市场制造和销售各种品牌产品。该公司前身为Grove,Inc.,并于2022年8月更名为Upexi,Inc.Upexi,Inc.成立于2018年,总部位于佛罗里达州克利尔沃特。
About Exactus
关于Exactus
(Get Rating)
(获取评级)
Exactus, Inc., is a farmer and manufacturer of hemp-derived phytocannabinoid products. The company sells its CBD products through its Green Goddess brand and third-party resellers. Exactus is engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3 percent or less. THC is the psychoactive compound found in cannabis.
Exactus,Inc.是一家从大麻中提取植物大麻素产品的农民和制造商。该公司通过其绿色女神品牌和第三方经销商销售其CBD产品。Exactus致力于从俄勒冈州的农场生产工业大麻,并计划通过cGMP设施直接提取和生产。工业大麻是一种大麻,联邦政府定义为THC(四氢大麻酚)含量不超过0.3%。THC是大麻中发现的具有精神活性的化合物。
Receive News & Ratings for Upexi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Upexi and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Upexi Daily》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Upexi和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧